The Role of GLUTATHIONE in HIV/AIDS. Part TWO

This week June 23, 2009 on the Glutathione and You Show, we want to look at Part Two of The Role of Glutathione in HIV/AIDS. An estimated 39.5 million people have HIV worldwide. In 2008, CDC estimated that approximately 56,300 people were newly infected with HIV in 2006(the most recent year that data are available, United States).The above statements were quoted from AIDS WATCH by Kendal Richardson article found in the Overground Railroad www.overgroundrr.com. In 1992, a team led by Dr.Gustavo Bounous investigated the properties of milk protein isolates at McGill University, Montreal, Canada. They developed a method of extraction that preserved the GSH-enhancing properties of the protein.The product was later patented and named IMMUNOCAL. Dr. Bounous and his colleagues knew that heightened GSH levels seemed to enhance the human immune system. Learning of the correlation between HIV progresion and low GSH levels, they studied its effects on AIDS patients. Their milk-protein isolate was given as a dietary supplement. The results were that it often diminished and sometimes reversed the wasting effects of AIDS. These patients also exhibited elevated CD4 T-Cell counts and decreased viral load. (The above information is on page 121 of "GSH Your Body's Most Powerful Protector GLUATHIONE" by Dr.Jimmy Gutman MD to order your copy www.kudo.ca).The Following questions we will be discussing: 1.What is HIV? 2. What is AIDS? 3.What are some of the symptoms of HIV/AIDS? 4. How is the Immune System affected by HIV?AIDS? 5.What role does Oxidative Stress have in HIV/AIDS? 6.How long does it take HIV to become AIDS? 7.How is HIV/AIDS treated? 8.What are some of the myths and misconceptions about HIV/AIDS? 9.How is HIV/AIDS transmitted? 10.How can you protect yourself? 11.What is the role of glutathione enhancement in HIV/AIDS? 12.How can glutathione supplementation as a mainstay of complementary therapy work for HIV/AIDS? Please visit our website at www.immunotec.com/respect4life or